[{"data":1,"prerenderedAt":136},["ShallowReactive",2],{"naujienos/nasas-space-healthcare-innovation-program-to-collaborate-with-lithuanias-delta-biosciences/en":3},{"status":4,"data":5},true,{"image":6,"id":14,"seo":15,"title":65,"date":91,"url":87,"fullUrl":26,"text":92,"excerpt":25,"more":93,"tags":134,"temos":135},{"src":7,"is_svg":8,"ratio":9,"width":10,"height":11,"alt":12,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2024/10/delta-bio-komandos-vizitas-eka-su-dr-hahn-1-1-3840x2880.jpeg",false,0.75,3840,2880,"NASA's Space Healthcare Innovation Program to Collaborate with Lithuania's Delta Biosciences","",6766,{"title":16,"robots":17,"og_locale":23,"og_type":24,"og_title":16,"og_description":25,"og_url":26,"og_site_name":27,"article_publisher":28,"og_image":29,"twitter_card":34,"schema":35,"breadcrumbs":79,"description":13,"language":88},"NASA's Space Healthcare Innovation Program to Collaborate with Lithuania's Delta Biosciences - Inovacijų agentūra",{"index":18,"follow":19,"max-snippet":20,"max-image-preview":21,"max-video-preview":22},"index","follow","max-snippet:-1","max-image-preview:large","max-video-preview:-1","en_US","article","Lithuanian life sciences company Delta Biosciences has become the first European company selected for NASA’s Space-H accelerator program, which promotes advanced space healthcare technologies. This opportunity was facilitated by an R&D contract signed in 2023 with the European Space Agency (ESA), through which the company began developing chemical compounds to protect astronauts from radiation during deep space missions. In collaboration with NASA, Delta Biosciences will contribute to innovative solutions in space healthcare, preparing for humanity's upcoming leap into deep space missions.","https://www.inovacijuagentura.lt/en/naujiena/nasas-space-healthcare-innovation-program-to-collaborate-with-lithuanias-delta-biosciences/","Inovacijų agentūra","https://www.facebook.com/inovacijuagentura",[30],{"width":31,"height":32,"url":7,"type":33},"4032","3024","image/jpeg","summary_large_image",{"@context":36,"@graph":37},"https://schema.org",[38,53,55,66,70],{"@type":39,"@id":26,"url":26,"name":16,"isPartOf":40,"primaryImageOfPage":42,"image":44,"thumbnailUrl":7,"datePublished":45,"breadcrumb":46,"inLanguage":48,"potentialAction":49},"WebPage",{"@id":41},"https://www.inovacijuagentura.lt/en/#website",{"@id":43},"https://www.inovacijuagentura.lt/en/naujiena/nasas-space-healthcare-innovation-program-to-collaborate-with-lithuanias-delta-biosciences/#primaryimage",{"@id":43},"2024-10-18T08:43:00+00:00",{"@id":47},"https://www.inovacijuagentura.lt/en/naujiena/nasas-space-healthcare-innovation-program-to-collaborate-with-lithuanias-delta-biosciences/#breadcrumb","en-US",[50],{"@type":51,"target":52},"ReadAction",[26],{"@type":54,"inLanguage":48,"@id":43,"url":7,"contentUrl":7,"width":31,"height":32,"caption":12},"ImageObject",{"@type":56,"@id":47,"itemListElement":57},"BreadcrumbList",[58,63],{"@type":59,"position":60,"name":61,"item":62},"ListItem","1","Home","https://www.inovacijuagentura.lt/en/",{"@type":59,"position":64,"name":65},"2","NASA’s Space Healthcare Innovation Program to Collaborate with Lithuania’s Delta Biosciences",{"@type":67,"@id":41,"url":62,"name":27,"description":13,"publisher":68,"inLanguage":48},"WebSite",{"@id":69},"https://www.inovacijuagentura.lt/en/#organization",{"@type":71,"@id":69,"name":27,"url":62,"logo":72,"image":77,"sameAs":78},"Organization",{"@type":54,"inLanguage":48,"@id":73,"url":74,"contentUrl":74,"width":75,"height":76,"caption":27},"https://www.inovacijuagentura.lt/en/#/schema/logo/image/","https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/ia-logo-main.svg","1886","786",{"@id":73},[28],[80,83,86],{"url":81,"text":61,"id":82},"/en/",7576,{"url":84,"text":85},"/en/news/","News",{"url":87,"text":65,"id":14},"/en/naujiena/nasas-space-healthcare-innovation-program-to-collaborate-with-lithuanias-delta-biosciences/",[89],{"url":26,"code":90,"locale":90,"default":8},"en","2024-10-18","\u003Cp style=\"text-align:justify\">According to \u003Cem>Delta Biosciences\u003C/em> founder, Dominykas Milašius, this project marks the company’s entry into a new industry – astrochemistry – where biochemical research is applied to space exploration.\u003C/p>\n\u003Cp style=\"text-align:justify\">"This project will help expand scientific research in astrochemistry. Our partnership with ESA encouraged us to adapt our biochemical research technologies for space exploration. The recognition by \u003Cem>Space-H\u003C/em> motivates us even more to contribute to reducing the harmful effects of space on human health. We are now preparing for the next step – experimental validation of our research in orbit. We aim to conduct experiments on the International Space Station and delve deeper into space medicine development," said Milašius.\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cem>Head of “Space Hub LT” \u003C/em>at Innovation Agency Lithuania, Eglė Elena Šataitė, hopes that the success of \u003Cem>Delta Biosciences\u003C/em> will serve as an example for other companies and research institutions, and that soon Lithuania could establish itself as a leader in astrochemistry.\u003C/p>\n\u003Cp style=\"text-align:justify\">"In our 2022 space strategy, we identified that scientific research, innovations, and the knowledge developed in Lithuania’s life sciences sector hold significant potential for the space industry. Together with ESA experts, we strive to ensure that the achievements in this sector gain recognition across Europe, and that Lithuanian life sciences companies and research institutions explore opportunities in space. We organize seminars, individual consultations with ESA experts, and visits – these are important for creating breakthroughs in this field," said Šataitė.\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>Radiation Protection for Both Astronauts and Cancer Patients\u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cem>Delta Biosciences\u003C/em> is currently focused on developing radioprotective compounds in partnership with ESA, which could protect astronauts from cosmic radiation. These studies are crucial for long-term deep space exploration, especially for planned human missions to the Moon and Mars.\u003C/p>\n\u003Cp style=\"text-align:justify\">“Our collaboration with \u003Cem>Delta Biosciences\u003C/em> is part of ESA’s broader strategy to deepen our understanding of how to protect human health during space missions,” commented Dr. Christiane Hahn, Portfolio Scientist at ESA’s  Human Exploration Science Team within the Human and Robotic Exploration directorate. “Delta’s innovative approach to radioprotective compounds could support future exploration beyond low Earth orbit.”\u003C/p>\n\u003Cp style=\"text-align:justify\">Dr. Donatas Žmuidinavičius, Chief Technology Officer at \u003Cem>Delta Biosciences\u003C/em>, revealed that their work with ESA and \u003Cem>Space-H\u003C/em> is part of a larger advanced scientific research project with broader applications.\u003C/p>\n\u003Cp style=\"text-align:justify\">"These studies are important not only for rescue teams and aerospace crews working in extreme conditions, who are regularly exposed to increased radiation, but also have medical benefits for cancer patients undergoing radiotherapy. We are pursuing a dual-use testing plan – for both Earth and space applications," said Žmuidinavičius.\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>Focus on Commercial Space Travelers\u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cem>Delta Biosciences\u003C/em> has also become one of twelve companies worldwide selected for the inaugural \u003Cem>Space-H Space Health Accelerator\u003C/em> group. This program is a unique collaboration among aerospace giants \u003Cem>Starburst\u003C/em>, NASA’s Human Research Program (NASA HRP), the Translational Research Institute for Space Health (TRISH), the \u003Cem>Methuselah Foundation\u003C/em>, and \u003Cem>Microsoft\u003C/em>. Its focus is on new autonomous health and medical systems required for missions to the Moon, Mars, and for commercial space travelers spending extended periods in low Earth orbit.\u003C/p>\n\u003Cp style=\"text-align:justify\">“Science accelerators are a great way to spur innovation and technical advancement. That’s why NASA’s so interested in science accelerators focused on space health–as the commercial space sector expands, more people from all walks of life will be going into space. We’re really looking for ideas that will push clinical care in space forward to meet the needs of a larger astronaut pool," said Jancy McPhee, Chief Scientist at NASA’s Human Research Program.\u003C/p>\n\u003Cp style=\"text-align:justify\">“The Artemis program and the growth of the Low Earth Orbit (LEO) economy, including space tourism and in-space research and manufacturing, are creating new opportunities to advance biological  research  and  to  support  the  development  of  advanced,  fully  autonomous,  medical systems,” said Elizabeth Reynolds, \u003Cem>Starburst \u003C/em>Managing Director. “New technologies developed in support of space exploration will not only protect space travelers but have the potential to improve healthcare outcomes and equity here on Earth.”\u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cem>Delta Biosciences\u003C/em> is the only European company selected for the \u003Cem>Space-H\u003C/em> program. Other participants include international pioneers in space health, such as \u003Cem>ANYg Bio\u003C/em>, \u003Cem>Ejenta\u003C/em>, \u003Cem>Esperto Medical\u003C/em>, \u003Cem>GattaCo\u003C/em>, \u003Cem>Innsightful\u003C/em>, \u003Cem>LinkGevity\u003C/em>, \u003Cem>Mitrix Bio\u003C/em>, \u003Cem>Nahlia\u003C/em>, \u003Cem>NaNotics\u003C/em>, \u003Cem>Space REDI\u003C/em>, and \u003Cem>Synapsis Medical\u003C/em>.\u003C/p>\n",[94,103,112,126],{"image":95,"title":98,"url":99,"id":100,"text":101,"temos":102},{"src":96,"is_svg":8,"ratio":97,"alt":98,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/kosmoso-memorandumas-su-polsa.jpg",0.6669921875,"Lithuania Strengthens Cooperation with Poland and the United States in the Space Sector: Important Memorandums Signed","/en/naujiena/lithuania-strengthens-cooperation-with-poland-and-the-united-states-in-the-space-sector-important-memorandums-signed/",6748,"Lithuania’s space sector continues to strengthen international partnerships and expand cooperation with key players in the global space industry. Innovation Agency Lithuania has recently signed two significant memorandums of understanding – with the Polish Space Agency (POLSA) and the U.S. space infrastructure company Vast. These agreements open new opportunities for Lithuanian businesses, research institutions, and international projects.",[],{"image":104,"title":107,"url":108,"id":109,"text":110,"temos":111},{"src":105,"is_svg":8,"ratio":106,"alt":107,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/03/shutterstock-2539768243-1.jpg",0.7490234375,"Lithuania Ranks First in Europe in the Global Entrepreneurship Index","/en/naujiena/lithuania-ranks-first-in-europe-in-the-global-entrepreneurship-index/",6892,"The latest Global Entrepreneurship Monitor (GEM) 2025/2026 global report shows that Lithuania is the leading country in Europe in terms of the quality of its entrepreneurial environment and ranks among the world’s strongest economies in this field.",[],{"image":113,"title":115,"url":116,"id":117,"text":118,"temos":119},{"src":114,"is_svg":8,"ratio":97,"alt":115,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/01/karolina-urbonaite.jpg","Lithuania’s Startup Ecosystem Surpasses €16.4 Billion in Value: Investments Jump 1.7x in 2025","/en/naujiena/lithuanias-startup-ecosystem-surpasses-e16-4-billion-in-value-investments-jump-1-7x-in-2025/",6999,"The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just one year, Lithuanian startups attracted €220 million in venture capital investments from 77 unique investors. The ecosystem’s growing maturity was further confirmed earlier this year with the addition of a new unicorn to Lithuania’s startup map — Cast AI.",[120,123],{"id":121,"name":122},577,"Growth",{"id":124,"name":125},579,"Innovation",{"image":127,"title":129,"url":130,"id":131,"text":132,"temos":133},{"src":128,"is_svg":8,"ratio":97,"alt":129,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/12/modix-fgf-3d-spausdintuvas-2.jpg","Mission-Driven Innovations: Science and Business Shaping Lithuania’s Future","/en/naujiena/mission-driven-innovations-science-and-business-shaping-lithuanias-future/",6904,"Some important scientific research activities and innovative business-developed products may sound complex – unsurprisingly, as they are developed by people who dedicate their entire lives to these fields. Yet behind these sophisticated terms lie concrete solutions that will eventually make each of our daily lives easier. Where science and business join forces, more accurate disease diagnostics for the health of us and our loved ones are developed, cybersecurity tools are created to protect the country, and climate-neutral production technologies and materials emerge to help preserve our nature and resources.",[],[],[],1780325202819]